This analysis examines the historical and forecast performance for Menarini in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Key reasons to purchase this title
- Benchmark Menarinis performance against key rivals in the prescription pharmaceutical sector
- Discover how the companys business model continues to drive sales growth across the established and emerging European markets
- Assess Menarinis position in the hypertension market and the various challenges that its broad antihypertensive portfolio could face
